APOC3 and Alzheimer disease: For instance, the level of apoA-I [87, 89, 92] and apoC-III [92] in plasma, and apoD in CSF [95, 96] were measured to be lower in AD patients compared to non-demented controls, thus suggesting reduced activities of these proteins in lipid metabolism.